Involvement of CSCs in tamoxifen resistance of breast cancer cells has been reported, which appears to be mechanistically linked with higher expression of CXCR4 [26], STAT3 [27], Sox2 [28], EZH2 [29], and lower expression of CD24 [30, 31]. This evidence concerns the gene EZH2 and breast cancer.